ITCI
Intra-Cellular Therapies Inc
Price:  
131.87 
USD
Volume:  
16,042,154.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI Relative Valuation

-110.0%
Upside

As of 2025-06-17, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.0%.

The range of the Relative Valuation is (13.00) - (12.80) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.7x - 18.3x 18.1x
Forward P/E multiples 18.5x - 20.1x 19.5x
Fair Price (13.00) - (12.80) (13.18)
Upside -109.9% - -109.7% -110.0%
131.87 USD
Stock Price
(13.18) USD
Fair Price

ITCI Relative Valuation - Historical P/E Data

Date P/E
2025-04-01 -188.10
2025-03-31 -188.17
2025-03-28 -188.02
2025-03-27 -187.93
2025-03-26 -187.85
2025-03-25 -187.86
2025-03-24 -187.86
2025-03-21 -187.79
2025-03-20 -187.72
2025-03-19 -187.62
2025-03-18 -187.50
2025-03-17 -187.50